Verition Fund Management
INSM icon

Verition Fund Management’s Insmed INSM Stock Holding History

Verition Fund Management’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-16,043
Closed -$2.79M – 2907
2025
Q4 		$2.79M Sell
16,043
-12,109
-43% -$2.21M 0.01% 1314
2025
Q3 		$4.05M Sell
28,152
-65,218
-70% -$7.99M 0.02% 1363
2025
Q2 		$9.4M Buy
93,370
+66,896
+253% +$5.11M 0.04% 559
2025
Q1 		$2.02M Sell
26,474
-2,059
-7% -$158K 0.01% 1564
2024
Q4 		$1.97M Sell
28,533
-47,873
-63% -$3.45M 0.01% 1563
2024
Q3 		$5.58M Buy
76,406
+60,585
+383% +$4.47M 0.03% 783
2024
Q2 		$1.06M Buy
+15,821
New +$614K 0.01% 1636
2024
Q1 		– Sell
-10,199
Closed -$316K – 2868
2023
Q4 		$316K Sell
10,199
-6,501
-39% -$169K ﹤0.01% 1776
2023
Q3 		$422K Buy
16,700
+2,526
+18% +$57.8K ﹤0.01% 1533
2023
Q2 		$299K Sell
14,174
-13,213
-48% -$251K ﹤0.01% 1556
2023
Q1 		$467K Buy
+27,387
New +$532K 0.01% 1279
2022
Q4 		– Sell
-40,842
Closed -$880K – 2426
2022
Q3 		$880K Buy
+40,842
New +$979K 0.01% 1498

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Verition Fund Management's INSM Position: Q1 2026 in Review

Verition Fund Management sold out of Insmed (INSM) in Q1 2026, closing a stake of 16,043 shares — an estimated $2.79M sold.

Verition Fund Management first reported a position in INSM in Q3 2022 and held it in 12 quarters. The position peaked at $9.4M in Q2 2025. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Verition Fund Management reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Verition Fund Management sold 16,043 Insmed shares in Q1 2026, an estimated $2.79M.
  • Verition Fund Management first reported a position in Insmed in Q3 2022 and held it in 12 quarters.
  • Verition Fund Management's Insmed position peaked at $9.4M in Q2 2025.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Verition Fund Management's 13F filing for Q1 2026, filed 15 May 2026.